{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T11:34:40Z","timestamp":1792236880888,"version":"4.4.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1124\/dmd.119.089656","type":"journal-article","created":{"date-parts":[[2020,1,20]],"date-time":"2020-01-20T18:25:12Z","timestamp":1579544712000},"page":"245-254","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":99,"title":["Quantitative Proteomics of Clinically Relevant Drug-Metabolizing Enzymes and Drug Transporters and Their Intercorrelations in the Human Small Intestine"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7565-4357","authenticated-orcid":false,"given":"Narciso","family":"Couto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zubida M.","family":"Al-Majdoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela J.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2595-5626","authenticated-orcid":false,"given":"Brahim","family":"Achour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3481-8201","authenticated-orcid":false,"given":"Matthew D.","family":"Harwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon","family":"Carlson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Barber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3917-844X","authenticated-orcid":false,"given":"Amin","family":"Rostami-Hodjegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey","family":"Warhurst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.119.089656_bib1","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1124\/dmd.117.076703","article-title":"Quantitative characterization of major hepatic UDP-glucuronosyltransferase enzymes in human liver microsomes: comparison of two proteomic methods and correlation with catalytic activity","volume":"45","author":"Achour","year":"2017","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.119.089656_bib2","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1124\/dmd.113.055632","article-title":"Simultaneous quantification of the abundance of several cytochrome P450 and uridine 5\u2032-diphospho-glucuronosyltransferase enzymes in human liver microsomes using multiplexed targeted proteomics","volume":"42","author":"Achour","year":"2014","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.119.089656_bib3","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1021\/acs.molpharmaceut.7b00772","article-title":"High expression of UGT1A1\/1A6 in monkey small intestine: comparison of protein expression levels of cytochromes P450, UDP-glucuronosyltransferases, and transporters in small intestine of cynomolgus monkey and human","volume":"15","author":"Akazawa","year":"2018","journal-title":"Mol Pharm"},{"key":"10.1124\/dmd.119.089656_bib4","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/jnc.14446","article-title":"Identification and quantification of blood-brain barrier transporters in isolated rat brain microvessels","volume":"146","author":"Al Feteisi","year":"2018","journal-title":"J Neurochem"},{"key":"10.1124\/dmd.119.089656_bib5","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1021\/acs.molpharmaceut.8b01189","article-title":"Proteomic quantification of human blood-brain barrier SLC and ABC transporters in healthy individuals and dementia patients","volume":"16","author":"Al-Majdoub","year":"2019","journal-title":"Mol Pharm"},{"key":"10.1124\/dmd.119.089656_bib6","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1021\/pr400667h","article-title":"Quantification of the proteins of the bacterial ribosome using QconCAT technology","volume":"13","author":"Al-Majdoub","year":"2014","journal-title":"J Proteome Res"},{"key":"10.1124\/dmd.119.089656_bib7","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1021\/mp0600687","article-title":"Gene and protein expression of P-glycoprotein, MRP1, MRP2, and CYP3A4 in the small and large human intestine","volume":"4","author":"Berggren","year":"2007","journal-title":"Mol Pharm"},{"key":"10.1124\/dmd.119.089656_bib8","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1208\/s12248-009-9111-6","article-title":"Simulations of the nonlinear dose dependence for substrates of influx and efflux transporters in the human intestine","volume":"11","author":"Bolger","year":"2009","journal-title":"AAPS J"},{"key":"10.1124\/dmd.119.089656_bib9","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1021\/acs.molpharmaceut.7b00076","article-title":"Clinically relevant multidrug transporters are regulated by microRNAs along the human intestine","volume":"14","author":"Bruckmueller","year":"2017","journal-title":"Mol Pharm"},{"key":"10.1124\/dmd.119.089656_bib10","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1111\/bcp.13908","article-title":"Activity and mRNA expression levels of selected cytochromes P450 in various sections of the human small intestine","volume":"85","author":"Clermont","year":"2019","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/dmd.119.089656_bib11","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1021\/acs.molpharmaceut.8b00941","article-title":"Quantification of proteins involved in drug metabolism and disposition in the human liver using label-free global proteomics","volume":"16","author":"Couto","year":"2019","journal-title":"Mol Pharm"},{"key":"10.1124\/dmd.119.089656_bib12","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1016\/j.xphs.2018.06.013","article-title":"Past, present, and future of bioequivalence: improving assessment and extrapolation of therapeutic equivalence for oral drug products","volume":"107","author":"Cristofoletti","year":"2018","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.119.089656_bib13","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1124\/jpet.300.3.1036","article-title":"Unmasking the dynamic interplay between intestinal P-glycoprotein and CYP3A4","volume":"300","author":"Cummins","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.119.089656_bib14","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1126\/science.8153632","article-title":"Association of intestinal peptide transport with a protein related to the cadherin superfamily","volume":"264","author":"Dantzig","year":"1994","journal-title":"Science"},{"key":"10.1124\/dmd.119.089656_bib15","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1124\/dmd.114.058404","article-title":"Meta-analysis of the turnover of intestinal epithelia in preclinical animal species and humans","volume":"42","author":"Darwich","year":"2014","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.119.089656_bib16","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ejps.2019.02.017","article-title":"The nested enzyme-within-enterocyte (NEWE) turnover model for predicting dynamic drug and disease effects on the gut wall","volume":"131","author":"Darwich","year":"2019","journal-title":"Eur J Pharm Sci"},{"key":"10.1124\/dmd.119.089656_bib17","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/0091270006294279","article-title":"Incorporating in vitro information on drug metabolism into clinical trial simulations to assess the effect of CYP2D6 polymorphism on pharmacokinetics and pharmacodynamics: dextromethorphan as a model application","volume":"47","author":"Dickinson","year":"2007","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/dmd.119.089656_bib18","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1111\/bcp.13533","article-title":"Implications of intercorrelation between hepatic CYP3A4-CYP2C8 enzymes for the evaluation of drug-drug interactions: a case study with repaglinide","volume":"84","author":"Doki","year":"2018","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/dmd.119.089656_bib19","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/cpt.967","article-title":"Protein abundance of clinically relevant drug-metabolizing enzymes in the human liver and intestine: a comparative analysis in paired tissue specimens","volume":"104","author":"Drozdzik","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.119.089656_bib20","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1002\/cpt.1301","article-title":"Protein abundance of clinically relevant drug transporters in the human liver and intestine: a comparative analysis in paired tissue specimens","volume":"105","author":"Drozdzik","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.119.089656_bib21","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1021\/mp500330y","article-title":"Protein abundance of clinically relevant multidrug transporters along the entire length of the human intestine","volume":"11","author":"Drozdzik","year":"2014","journal-title":"Mol Pharm"},{"key":"10.1124\/dmd.119.089656_bib22","doi-asserted-by":"crossref","first-page":"107397","DOI":"10.1016\/j.pharmthera.2019.107397","article-title":"Quantitative mass spectrometry-based proteomics in the era of model-informed drug development: applications in translational pharmacology and recommendations for best practice","volume":"203","author":"El-Khateeb","year":"2019","journal-title":"Pharmacol Ther"},{"key":"10.1124\/dmd.119.089656_bib23","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.addr.2012.09.042","article-title":"Intestinal drug transporters: an overview","volume":"65","author":"Estudante","year":"2013","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1124\/dmd.119.089656_bib24","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s13000-015-0382-1","article-title":"Calreticulin down-regulation inhibits the cell growth, invasion and cell cycle progression of human hepatocellular carcinoma cells","volume":"10","author":"Feng","year":"2015","journal-title":"Diagn Pathol"},{"key":"10.1124\/dmd.119.089656_bib25","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/bcpt.13137","article-title":"Expression of clinically relevant drug-metabolizing enzymes along the human intestine and their correlation to drug transporters and nuclear receptors: an intra-subject analysis","volume":"124","author":"Fritz","year":"2019","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1124\/dmd.119.089656_bib26","series-title":"Developing Solid Oral Dosage Forms","first-page":"455","article-title":"Oral formulations for preclinical studies","author":"Gao","year":"2017"},{"key":"10.1124\/dmd.119.089656_bib27","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/sj.clpt.6100056","article-title":"Intestinal drug transporter expression and the impact of grapefruit juice in humans","volume":"81","author":"Glaeser","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.119.089656_bib28","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jpba.2013.07.031","article-title":"LC-MS\/MS-based quantification of clinically relevant intestinal uptake and efflux transporter proteins","volume":"85","author":"Gr\u00f6er","year":"2013","journal-title":"J Pharm Biomed Anal"},{"key":"10.1124\/dmd.119.089656_bib29","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1021\/ac201704a","article-title":"Quantification of human uridine-diphosphate glucuronosyl transferase 1A isoforms in liver, intestine, and kidney using nanobore liquid chromatography-tandem mass spectrometry","volume":"84","author":"Harbourt","year":"2012","journal-title":"Anal Chem"},{"key":"10.1124\/dmd.119.089656_bib30","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1124\/dmd.115.067777","article-title":"In vitro-in vivo extrapolation scaling factors for intestinal P-glycoprotein and breast cancer resistance protein: part II. The impact of cross-laboratory variations of intestinal transporter relative expression factors on predicted drug disposition","volume":"44","author":"Harwood","year":"2016","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.119.089656_bib31","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jpba.2015.02.043","article-title":"Application of an LC-MS\/MS method for the simultaneous quantification of human intestinal transporter proteins absolute abundance using a QconCAT technique","volume":"110","author":"Harwood","year":"2015","journal-title":"J Pharm Biomed Anal"},{"key":"10.1124\/dmd.119.089656_bib32","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/bdd.1810","article-title":"Absolute abundance and function of intestinal drug transporters: a prerequisite for fully mechanistic in vitro-in vivo extrapolation of oral drug absorption","volume":"34","author":"Harwood","year":"2013","journal-title":"Biopharm Drug Dispos"},{"key":"10.1124\/dmd.119.089656_bib33","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1124\/dmd.114.058446","article-title":"Lost in centrifugation: accounting for transporter protein losses in quantitative targeted absolute proteomics","volume":"42","author":"Harwood","year":"2014","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.119.089656_bib34","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1124\/dmd.119.086959","article-title":"The regional-specific relative and absolute expression of gut transporters in adult caucasians: a meta-analysis","volume":"47","author":"Harwood","year":"2019","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.119.089656_bib35","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.ejps.2008.08.004","article-title":"Comparison of drug transporter gene expression and functionality in Caco-2 cells from 10 different laboratories","volume":"35","author":"Hayeshi","year":"2008","journal-title":"Eur J Pharm Sci"},{"key":"10.1124\/dmd.119.089656_bib36","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1124\/dmd.107.014902","article-title":"Expression of thirty-six drug transporter genes in human intestine, liver, kidney, and organotypic cell lines","volume":"35","author":"Hilgendorf","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.119.089656_bib37","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s40495-016-0059-9","article-title":"Recent advances in development and application of physiologically-based pharmacokinetic (PBPK) models: a transition from academic curiosity to regulatory acceptance","volume":"2","author":"Jamei","year":"2016","journal-title":"Curr Pharmacol Rep"},{"key":"10.1124\/dmd.119.089656_bib38","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1074\/jbc.M109326200","article-title":"Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor","volume":"277","author":"Kast","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.119.089656_bib39","doi-asserted-by":"crossref","first-page":"105350","DOI":"10.1016\/j.jsbmb.2019.03.027","article-title":"Major glucuronide metabolites of testosterone are primarily transported by MRP2 and MRP3 in human liver, intestine and kidney","volume":"191","author":"Li","year":"2019","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1124\/dmd.119.089656_bib40","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1124\/dmd.30.7.795","article-title":"CYP3A4 induction by drugs: correlation between a pregnane X receptor reporter gene assay and CYP3A4 expression in human hepatocytes","volume":"30","author":"Luo","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.119.089656_bib41","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/bioinformatics\/btq054","article-title":"Skyline: an open source document editor for creating and analyzing targeted proteomics experiments","volume":"26","author":"MacLean","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1124\/dmd.119.089656_bib42","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1124\/dmd.106.013342","article-title":"Regional distribution of solute carrier mRNA expression along the human intestinal tract","volume":"35","author":"Meier","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.119.089656_bib43","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s10928-019-09627-6","article-title":"Accounting for inter-correlation between enzyme abundance: a simulation study to assess implications on global sensitivity analysis within physiologically-based pharmacokinetics","volume":"46","author":"Melillo","year":"2019","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"10.1124\/dmd.119.089656_bib44","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1021\/acs.molpharmaceut.6b00085","article-title":"Quantitative atlas of cytochrome P450, UDP-glucuronosyltransferase, and transporter proteins in jejunum of morbidly obese subjects","volume":"13","author":"Miyauchi","year":"2016","journal-title":"Mol Pharm"},{"key":"10.1124\/dmd.119.089656_bib45","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1002\/pmic.201500433","article-title":"Large-scale multiplex absolute protein quantification of drug-metabolizing enzymes and transporters in human intestine, liver, and kidney microsomes by SWATH-MS: comparison with MRM\/SRM and HR-MRM\/PRM","volume":"16","author":"Nakamura","year":"2016","journal-title":"Proteomics"},{"key":"10.1124\/dmd.119.089656_bib46","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1208\/s12248-015-9758-0","article-title":"Translating human effective jejunal intestinal permeability to surface-dependent intrinsic permeability: a pragmatic method for a more mechanistic prediction of regional oral drug absorption","volume":"17","author":"Olivares-Morales","year":"2015","journal-title":"AAPS J"},{"key":"10.1124\/dmd.119.089656_bib47","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1208\/s12248-013-9521-3","article-title":"Mass spectrometry-based targeted proteomics as a tool to elucidate the expression and function of intestinal drug transporters","volume":"15","author":"Oswald","year":"2013","journal-title":"AAPS J"},{"key":"10.1124\/dmd.119.089656_bib48","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1091\/mbc.e10-01-0081","article-title":"The polarized distribution of Na+,K+-ATPase: role of the interaction between \u03b2 subunits","volume":"21","author":"Padilla-Benavides","year":"2010","journal-title":"Mol Biol Cell"},{"key":"10.1124\/dmd.119.089656_bib49","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1124\/dmd.105.008672","article-title":"The human intestinal cytochrome P450 \u201cpie\u201d","volume":"34","author":"Paine","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.119.089656_bib50","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1124\/dmd.113.053819","article-title":"Interindividual variability in hepatic organic anion-transporting polypeptides and P-glycoprotein (ABCB1) protein expression: quantification by liquid chromatography tandem mass spectroscopy and influence of genotype, age, and sex","volume":"42","author":"Prasad","year":"2014","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.119.089656_bib51","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/clpt.2012.65","article-title":"Physiologically based pharmacokinetics joined with in vitro-in vivo extrapolation of ADME: a marriage under the arch of systems pharmacology","volume":"92","author":"Rostami-Hodjegan","year":"2012","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.119.089656_bib53","doi-asserted-by":"crossref","first-page":"5934","DOI":"10.1021\/pr400279u","article-title":"Alternative fusion protein strategies to express recalcitrant QconCAT proteins for quantitative proteomics of human drug metabolizing enzymes and transporters","volume":"12","author":"Russell","year":"2013","journal-title":"J Proteome Res"},{"key":"10.1124\/dmd.119.089656_bib54","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1124\/dmd.113.056291","article-title":"Optimized methods for targeted peptide-based quantification of human uridine 5\u2032-diphosphate-glucuronosyltransferases in biological specimens using liquid chromatography-tandem mass spectrometry","volume":"42","author":"Sato","year":"2014","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.119.089656_bib55","doi-asserted-by":"crossref","first-page":"27473","DOI":"10.1074\/jbc.M301106200","article-title":"Functional complementation between a novel mammalian polygenic transport complex and an evolutionarily ancient organic solute transporter, OSTalpha-OSTbeta","volume":"278","author":"Seward","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.119.089656_bib56","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ejps.2014.02.010","article-title":"In vivo methods for drug absorption - comparative physiologies, model selection, correlations with in vitro methods (IVIVC), and applications for formulation\/API\/excipient characterization including food effects","volume":"57","author":"Sj\u00f6gren","year":"2014","journal-title":"Eur J Pharm Sci"},{"key":"10.1124\/dmd.119.089656_bib57","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.addr.2011.07.007","article-title":"Oral drug delivery utilizing intestinal OATP transporters","volume":"64","author":"Tamai","year":"2012","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1124\/dmd.119.089656_bib58","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0009-9236(99)70017-2","article-title":"CYP2C19 genotype-related efficacy of omeprazole for the treatment of infection caused by Helicobacter pylori","volume":"66","author":"Tanigawara","year":"1999","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.119.089656_bib59","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1365-2125.2005.02389.x","article-title":"Cytochromes P450 and MDR1 mRNA expression along the human gastrointestinal tract","volume":"60","author":"Th\u00f6rn","year":"2005","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/dmd.119.089656_bib60","doi-asserted-by":"crossref","first-page":"E6","DOI":"10.1208\/aapsj070102","article-title":"A simultaneous assessment of CYP3A4 metabolism and induction in the DPX-2 cell line","volume":"7","author":"Trubetskoy","year":"2005","journal-title":"AAPS J"},{"key":"10.1124\/dmd.119.089656_bib61","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1177\/0091270007299930","article-title":"Nuclear receptors and the regulation of drug-metabolizing enzymes and drug transporters: implications for interindividual variability in response to drugs","volume":"47","author":"Urquhart","year":"2007","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/dmd.119.089656_bib62","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nmeth.1322","article-title":"Universal sample preparation method for proteome analysis","volume":"6","author":"Wi\u015bniewski","year":"2009","journal-title":"Nat Methods"},{"key":"10.1124\/dmd.119.089656_bib63","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1124\/dmd.112.045575","article-title":"Evaluation of six proton pump inhibitors as inhibitors of various human cytochromes P450: focus on cytochrome P450 2C19","volume":"40","author":"Zvyaga","year":"2012","journal-title":"Drug Metab Dispos"}],"updated-by":[{"DOI":"10.1124\/dmd.119.089656err","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000}}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624076992?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624076992?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.119.089656","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T09:18:12Z","timestamp":1739956692000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624076992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":62,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0090955624076992"],"URL":"https:\/\/doi.org\/10.1124\/dmd.119.089656","relation":{"erratum":[{"id-type":"doi","id":"10.1124\/dmd.119.089656err","asserted-by":"object"}]},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantitative Proteomics of Clinically Relevant Drug-Metabolizing Enzymes and Drug Transporters and Their Intercorrelations in the Human Small Intestine","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.119.089656","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by The Author(s)","name":"copyright","label":"Copyright"}]}}